Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-02-04 @ 1:30 AM
Study NCT ID:
NCT00521859
Status:
COMPLETED
Last Update Posted:
2012-07-31
First Post:
2007-08-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hematologic Malignancies | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Hematologic Malignancies | View |
| None | Leukemia | View |
| None | Lymphoma | View |
| None | Myeloma | View |
| None | Hodgkin's Disease | View |
| None | Hematopoietic Cell Transplantation | View |
| None | Cloretazine | View |
| None | VNP40101M | View |
| None | Fludarabine | View |
| None | Fludarabine Phosphate | View |
| None | Fludara | View |
| None | ATG | View |
| None | Antithymocyte | View |
| None | Thymoglobulin | View |